109 related articles for article (PubMed ID: 21851364)
1. Enrichment of invariant natural killer T cells in the bone marrow of visceral leishmaniasis patients.
Rai AK; Thakur CP; Seth T; Mitra DK
Parasite Immunol; 2011 Dec; 33(12):688-91. PubMed ID: 21851364
[TBL] [Abstract][Full Text] [Related]
2. Early activated Th-1 type and dominantly diverse natural killer T (CD3⁺CD161⁺Vα24⁻) cells in bone marrow among visceral leishmaniasis patients.
Rai AK; Thakur CP; Seth T; Mitra DK
Int J Parasitol; 2011 Aug; 41(10):1069-77. PubMed ID: 21787777
[TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis.
Kumari S; Jamal F; Shivam P; Thakur A; Kumar M; Bimal S; Das VN; Pandey K; Narayan S; Gupta AK; Das P; Singh SK
Cytokine; 2015 May; 73(1):53-60. PubMed ID: 25697139
[TBL] [Abstract][Full Text] [Related]
4. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic complications of visceral leishmaniasis].
Niggli F; Halle F; Seger RA
Monatsschr Kinderheilkd; 1991 Nov; 139(11):772-4. PubMed ID: 1775144
[TBL] [Abstract][Full Text] [Related]
6. Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages.
Karmakar S; Paul J; De T
Eur J Immunol; 2011 May; 41(5):1376-87. PubMed ID: 21425159
[TBL] [Abstract][Full Text] [Related]
7. T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load.
Kumar P; Misra P; Thakur CP; Saurabh A; Rishi N; Mitra DK
Clin Exp Immunol; 2018 Mar; 191(3):318-327. PubMed ID: 29058314
[TBL] [Abstract][Full Text] [Related]
8. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
[TBL] [Abstract][Full Text] [Related]
9. Visceral leishmaniasis in two cases of leukemia.
Sah SP; Rijal S; Bhadani PP; Rani S; Koirala S
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):25-7. PubMed ID: 12118454
[TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani mediated higher expression of CCL4 induces differential accumulation of CD4
Kumari S; Shivam P; Kumar S; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
Cytokine; 2018 Oct; 110():306-315. PubMed ID: 29807685
[TBL] [Abstract][Full Text] [Related]
11. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
[TBL] [Abstract][Full Text] [Related]
12. Dual immune effect of iNKT cells considering human cutaneous and visceral leishmaniasis: An example of cell plasticity according to different disease scenarios.
Gois BM; Peixoto RF; Maciel BLL; Gomes JAS; de Azevedo FLAA; Veras RC; de Medeiros IA; de Lima Grisi TCS; de Araújo DAM; do Amaral IPG; Keesen TSL
Scand J Immunol; 2018 Jun; 87(6):e12668. PubMed ID: 29701883
[TBL] [Abstract][Full Text] [Related]
13. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani-induced expression of signal regulatory protein alpha on Kupffer cells enhances hepatic invariant NKT-cell activation.
Beattie L; Svensson M; Bune A; Brown N; Maroof A; Zubairi S; Smith KR; Kaye PM
Eur J Immunol; 2010 Jan; 40(1):117-23. PubMed ID: 19877019
[TBL] [Abstract][Full Text] [Related]
15. iNKT cells in microbial immunity: recognition of microbial glycolipids.
Kinjo Y; Ueno K
Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
[TBL] [Abstract][Full Text] [Related]
16. Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis.
Elshafie AI; Hlin E; Håkansson LD; Elghazali G; Safi SH; Rönnelid J; Venge P
Int J Parasitol; 2011 Mar; 41(3-4):463-9. PubMed ID: 21172349
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
18. Flowers in a bone marrow aspiration.
Daneshbod Y; Dehghani SJ; Nikzad M; Daneshbod K
Am J Hematol; 2008 Dec; 83(12):935-6. PubMed ID: 18213653
[No Abstract] [Full Text] [Related]
19. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
[TBL] [Abstract][Full Text] [Related]
20. [A case of visceral leishmaniasis].
Cruz-López O; Tamariz-Cruz O; Gándara-Ramírez JL; Rojas-Domínguez R; Cárdenas-Perea ME
Rev Invest Clin; 1997; 49(3):231-5. PubMed ID: 9380977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
